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The intestinal microbiota has become a relevant aspect of human health. Microbial colonization runs in
parallel with immune system maturation and plays a role in intestinal physiology and regulation. Increasing
evidence on early microbial contact suggest that human intestinal microbiota is seeded before birth. Maternal
microbiota forms the first microbial inoculum, and from birth, the microbial diversity increases and
converges toward an adult-like microbiota by the end of the first 35 years of life. Perinatal factors such as
mode of delivery, diet, genetics, and intestinal mucin glycosylation all contribute to influence microbial
colonization. Once established, the composition of the gut microbiota is relatively stable throughout adult
life, but can be altered as a result of bacterial infections, antibiotic treatment, lifestyle, surgical, and a long-
term change in diet. Shifts in this complex microbial system have been reported to increase the risk of disease.
Therefore, an adequate establishment of microbiota and its maintenance throughout life would reduce the
risk of disease in early and late life. This review discusses recent studies on the early colonization and factors
influencing this process which impact on health.
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T
he microbiota is composed of a significant number
of different bacteria, approximately 160 species
per person per fecal sample, and this ecosystem
plays an important role in human health. The microbial
colonization of the infant gut is known to play a key role
in immunological and metabolic pathways impacting on
human health. Disruptions during this complex process
of microbial colonization have been shown to increase
the disease susceptibility during life. Alteration in the
compositional development of the gut microbiota of a
newborn has been demonstrated in a few studies to
predispose to diseases later in life. This review highlights
the recent observations on the importance of micro-
bial exposition during early life and the microbial
development throughout life. This microbial coloniza-
tion process promotes short- and long-term health
benefits and different factors that modify the microbial
composition.
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Microbial colonization of the infant gut
Colonization of the infant gastrointestinal (GI) tract by
microbes is an essential process in our life cycle since
microbiotahost interactions have an important influence
on human health and disease. Since the studies of Tissier
(1) concerning the acquisition of the infant gut micro-
biota, the idea that fetuses are sterile in utero and that
microbial colonization of the newborn starts during and
after birth has been widely accepted. More than a century
later, the hypothesis that the placenta barrier keeps fetuses
sterile throughout a healthy pregnancy still remains a
general dogma and, as a consequence, the presence of any
bacteria in the uterus is generally considered as a potential
danger for the fetus. This view arises from the fact that,
during decades, microbiological analyses of pregnancy-
related biological samples (chorioamnion, amniotic fluid,
and meconium) were only performed in cases where an
intrauterine infection was evident or suspected. Indeed,
several studies have found a strong correlation between
preterm deliveries and intrauterine infections (2, 3), the
leading cause of infant mortality worldwide (4).
In contrast, relatively few studies have examined the
uterine microbiota associated with healthy term pregnan-
cies, partly because of the enduring influence of the sterile
womb paradigm, and also due to the technical and ethi-
cal issues of collecting samples from healthy pregnancies
before birth. However, investigations into the potential
for bacterial transmission through the placental barrier
have detected bacteria in placenta tissue (5), umbilical
cord blood (6), amniotic fluid (79), and fetal membranes
(9, 10) from healthy newborns without any indication of
infection or inflammation.
Prenatal microbial contact: is there a fetal gut
microbiota?
Meconium is not sterile, as was previously assumed, since
it harbors a complex microbial community (8, 1114).
A recent study characterized the microbiota of meconium
and fecal samples obtained from preterm babies during
the first 3 weeks of life using culture-dependent and
culture-independent techniques (12). Both approaches
provided similar results and showed that spontaneously
released meconium of such neonates contains a specific
microbiota that differs from those observed in early fecal
samples. Firmicutes was the main phylum detected in
meconium while Proteobacteria was abundant in feces.
Culture-based techniques showed that staphylococci pre-
dominated in meconium while enterococci and certain
gram-negative bacteria, such as Escherichia coli, Klebsiella
pneumoniae, or Serratia marcescens, were more abundant
in fecal samples. In addition, 16S rRNA gene-based mic-
roarrays revealed the high prevalence of bacteria related
to Streptococcus mitis and Lactobacillus plantarum in
meconium, whereas those related to E. coli, Enterococcus,
and K. pneumoniae predominated in the infant feces.
In another study, the diversity of the meconium micro-
biome was assessed by multi-barcode 16S rRNA gene
sequencing using samples collected from 23 newborns
stratified by maternal diabetes status (13). All meconium
samples contained a diversified microbiota, which was
not affected by the mode of delivery; in comparison with
adult feces, meconium samples showed a lower species
diversity and a higher sample-to-sample variation. Taxo-
nomic analyses suggested that the overall bacterial content
in meconium significantly differed by maternal diabetes
status. Specifically, the phyla Bacteroidetes and the genus
Parabacteroides were enriched in those samples of the
diabetes group (13). It has also reported that meconium
microbiota types dominated by lactic acid or enteric
bacteria are differentially associated with maternal eczema
and later respiratory problems in infants (11).
While vaginal microbes associated with preterm birth
can get access to the uterine environment through an
ascending route, the mechanisms by which gut bacteria
reach this human niche are not well understood. It has
been suggested that bacteria travel to the placenta via
the bloodstream after gut epithelium translocation. While
the intestinal epithelial barrier generally prevents micro-
bial entry into the circulatory system, dendritic cells can
actively penetrate the gut epithelium, take up bacteria
from the intestinal lumen, and transport the live bacteria
throughout the body as they migrate to lymphoid organs
(15, 16). To test whether maternal gut bacteria can
be transferred to fetuses in utero, two pioneer studies
investigated if oral administration of a genetically labeled
Enterococcus faecium to pregnant mice resulted in its
presence in amniotic fluid and meconium of term off-
spring after sterile cesarean section (C-section) (6, 8).
Remarkably, E. faecium with the genetic label was cul-
tured from the amniotic fluid and meconium of pups from
inoculated mothers, but not from pups of control mice.
Thus, these studies provided foundational evidence for
maternal microbial transmission in mammals. Interest-
ingly, physiological bacterial translocation is highly in-
creased during pregnancy and lactation in rodents (17).
Globally, the dogma that the fetus resides in a sterile
environment is being challenged by recent findings, and
clearly, the question has arisen whether microbes that
colonize the fetus may be related to a better or worse
pregnancy outcome and to the future health status of
the neonate. Thus, some microorganisms colonizing the
placenta, such as Prevotella and Gardnerella, may provoke
distinctive newborn inflammatory responses while others,
such as Lactobacillus, may suppress these responses (18, 19).
Moreover, a previous study carried out in pregnant women
focused on the influence of oral microbiota composi-
tion in the pregnancy outcome and showed that some
bacteria, such as Actinomyces naselundii, were associated
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with lower birth weight and earlier delivery, while others,
such as lactobacilli, were linked with a higher birth
weight and later delivery date (20). Thus, it is possible
that oral bacteria can enter the uterine environment
through the bloodstream and may influence the delivery
process. These findings are also supported by recent exten-
sive deep sequencing studies in normal healthy term
pregnancies, identifying a low abundance, but metaboli-
cally rich placental microbiome, with a composition
resembling the oral microbiome more than the vaginal,
fecal, skin, or nasal microbiomes (5). In a recent review,
maternal microbial transmission has been reported to
occur in all animal kingdoms (21). ‘Heirloom’ microbes
received from the mother may be uniquely evolved to
the offspring’s genotype and vertical as compared with
horizontal transmission may increase the chance for
optimal mutualism (21).
We still know very little about the identity and number
of microbes that traverse the placenta, whether they persist
in the infant or whether their presence has short- or long-
term health consequences. The advent of high-throughput
system biology approaches will lead to a characterization
of the ‘fetal microbiome’ in utero and its health connota-
tions, including effects on immune imprinting.
Infant microbial colonization process
Microbial contact during prenatal life may imprint the
offspring microbiota and immune system in preparation
for the much larger inoculum transferred during vaginal
delivery and breastfeeding. A remarkably wide diversity
of bacteria can colonize the child when exposed to the
postnatal environment  being reflected by a high inter-
individual diversity in the gut microbiota composition of
newborns (22, 23). Advances in metagenomic technolo-
gies have revealed the composition of the human gut
microbiota from early infancy (22) through to old age (24).
Following birth, the human intestine is rapidly colo-
nized by an array of microbes and factors known to
influence colonization include gestational age, mode of
delivery (vaginal birth vs. assisted delivery), diet (breast
milk vs. formula), sanitation, and antibiotic treatment
(25, 26). First colonizers, facultative anaerobes, create a
new environment that promotes the colonization of strict
anaerobes as Bacteroides, Clostridium, and Bifidobacterium
spp. The intestinal microbiota of neonates is characterized
by low diversity and a relative dominance of the phyla
Proteobacteria and Actinobacteria, with the microbiota
becoming more diverse with the emergence and domi-
nance of Firmicutes and Bacteroidetes as time after birth
increases (2729). By the end of the first year of life,
infants possess an individually distinct microbial profile,
converging toward the characteristic microbiota of an
adult, such that by 25 years of age, the microbiota fully
resembles that of an adult in terms of composition and
diversity (22, 30, 31). Therefore, the first 3 years of life
represent the most critical period for dietary interventions
to improve child growth and development. This is the
period when the intestinal microbiota, a vital asset for
health and neurodevelopment (32) is established and
its alteration during this period has the potential to pro-
foundly affect host health and development. Gut micro-
biome development has been studied far more than that in
other body habitats and oral, skin and respiratory infant
microbial colonization processes are still being uncovered.
Gut microbiota development is affected by different
factors such as mode of delivery, diet, genetics, health
status, gestational age, etc. (Fig. 1).
Fig. 1. Factors influencing the infant gut microbiota development and the adult and elderly microbiota. The first 3 years of life
represents the most critical period for dietary interventions aimed at microbiota modulation to improve child growth and development
and positively affect health.
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Factors influencing infant microbiota
development
Mode of delivery
Initial postnatal microbial exposure occurs during and
shortly after birth. Vaginally delivered infants are colo-
nized by maternal vaginal and fecal bacteria, including
Lactobacillus and Bifidobacterium spp. (33). Infants born
via C-section are not directly exposed to maternal mic-
robes and are instead colonized with microbes associated
with the skin and the hospital environment. It is sug-
gested that the microbiota composition in these infants
may remain disturbed for months or even years (34, 35).
During vaginal delivery there is an extensive transmission
of vaginal bacteria from the mother to the child. The
vaginal microbiota has a low diversity, being mainly
composed of lactobacilli (36). During the first few days
of life there is a relatively high load of lactobacilli in the
neonatal gut, probably reflecting the vaginal microbiota
(23). Human anatomy also supports that exposure to
the mother’s fecal microbiota is an important transmis-
sion route during delivery (37). The facultative anaerobic
Enterobacteriaceae represents one of the bacterial groups
with the most probable direct transmission from mother
to child through feces (38). It has also been suggested that
Bacteroides fragilis is transmitted during, or just after,
delivery (39). Vaginally delivered infants, but not infants
born by C-section, shared a significantly higher propor-
tion of gut microbiota 16S rRNA gene sequences with
their own mother than with other mothers for up to
2 years of age, particularly within the Bacteroidetes and
Firmicutes phyla (35). As these anaerobic phyla do not
appear to grow outside the gut, it is probable that they
are transmitted between human hosts (40).
It has also been argued that strictly anaerobic clostridia
are unlikely to be transmitted directly during delivery
due to the oxygen tension in the gut at birth. Although
vegetative cells of human-derived clostridia are highly
sensitive toward oxygen, the spore form survive harsh
conditions  such as treatment with 3% chloroform 
and are still able to colonize the gut of gnotobiotic mice
(41). Spores would therefore provide an avenue for
transmission at a later stage. Further support for lack of
direct transmission of strictly anaerobic clostridia comes
from the finding that clostridia were highly overrepre-
sented in mothers, but not in their children up to the age
of 4 months (23, 42).
It has been known from the mid-1980s that breaking
the fecal and vaginal transmission route by C-section has
a major impact on the infant gut microbiota (43). Despite
major methodological changes and improvements, the
main conclusion that C-section delays Bacteroidetes
colonization still holds true (35). In recent reports, it has
also been shown that microbiota diversity is decreased
with C-section, compared to vaginal delivery (35).
Another important early source of colonizing micro-
biota is through the contact with the mother’s skin (44).
Skin-associated bacteria belonging to the Staphylococcus
genus, which is also widespread among different human
mucosal surfaces, are one of the earliest colonizers of the
human infant (45); they are rapidly outcompeted by other
bacteria with age.
Infant diet
Another relevant and strong influence in the infant
gut microbial development is the mode of feeding. In a
single case study, the infant microbiota development
was followed from birth to 2.5 years of age and results
demonstrated a clear dietary influence on the microbiota
composition (30). A major source for bacterial coloniza-
tion of the infant gut is through bacteria in the mother’s
milk, and it has been proposed that this mode of colo-
nization plays a major role in the child’s health status
(46). The mother’s milk microbiota mainly includes
streptococci and staphylococci followed by other bacteria
(47), which are among the earliest colonizers of the infant
gut (22, 23). Breast-fed infants are exposed to the milk
microbiota which has been reported to contain more than
700 species of bacteria (48). A higher maternal body mass
index (BMI) was associated with lower microbial diver-
sity in this study, as was emergency C-section compared
with planned C-sections and vaginal birth. Breast milk
also contains an abundance of complex oligosaccharides
with prebiotic activity, stimulating the growth of specific
bacterial groups such as staphylococci (47) and bifido-
bacteria (49). Gut microbiota diversity increases fol-
lowing weaning and introduction of solid food, with
enhanced colonization of butyrate producers, including
Bacteroides and certain Clostridium species (30, 50). The
oral microbiota consists of a highly diverse assemblage
of microorganisms (51). The child’s gut microbiota is
also exposed to the mother’s and its own oral microbiota 
either directly or indirectly through mother’s milk (48).
Recent evidence suggests that oral bacteria can colonize
the gut of infants, and as an example, oral Bifidobacterium
dentium has been found to be both highly abundant and
prevalent in the infant gut (52).
Antibiotics and preterm birth
Perturbation of optimal microbiota development, arising
from preterm birth or antibiotics has likely long-term
implications for microbial diversity and consequent
health. In preterm infants, the microbiota is characterized
by reduced diversity and higher levels of potentially
pathogenic bacteria and lower numbers of Bifidobacterium
and Bacteroides compared with full-term infants (53).
Even short-term antibiotic treatment can significantly
affect the evolution of the infant gut microbiota; in fact,
the colonization pattern of Bifidobacterium seems to be
particularly disturbed up to 8 weeks after treatment while
Proteobacteria are increased (54). Preterm delivery is
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often confounded with both C-section and antibiotic
usage since these three factors are often associated. Inde-
pendent of these confounders, however, the microbiota of
preterm infants is distinct to that of infants delivered
at term. The main patterns are increased Enterococcus,
together with Proteobacteria. In addition, there are lower
levels of bifidobacteria compared to that expected for
children delivered at term (12). Preterm birth is also
associated with neonatal necrotizing enterocolitis (NEC),
a severe inflammatory intestinal disorder. NEC has re-
cently been linked to the microbiota, where high levels
of Proteobacteria are predictive of the disease (55).
Environment and lifestyle
The family members and close relatives (siblings) have also
been described as a relevant environmental factor influen-
cing infant gut microbiota colonization. Thus, siblings
have higher proportion of Bifidobacterium spp. than single
infants (56). Geographical location also has an impact
on the microbiota, as microbiota differences are related
to dietary patterns and lifestyle in a specific area (city,
town, country, religion, etc.). It has been reported that
a ‘geographical gradient’ exists in the European infant
microbiota where infants from Northern areas have higher
levels of Bifidobacterium spp. and some Clostridium spp.
and Atopobium spp., while Southern infants had a higher
abundance of Eubacteria, Lactobacillus, and Bacteroides
(50). Significant differences between the microbiota of
Finnish and German infants (57) or between that of
Estonian and Swedish ones (58) have been also reported.
In the first study, the proportion of Bifidobacterium
spp. was higher in the Finnish than in the German infants,
who showed a higher abundance of the Bacteroides
Prevotella group and Akkermansia muciniphila. Another
study reported higher levels of Bifidobacterium spp.,
BacteroidesPrevotella, and Clostridium histolyticum in
Malawi infants than Finnish infants at the age of 6 months
(59). Furthermore, the gut microbiota of infants from
Burkina Faso (rural village) was characterized by an
enrichment of Bacteroides, while Enterobacteriaceae was
predominant in Italian children (60). In a recent study,
the healthy infant microbiota from the Amazonas of
Venezuela, rural Malawi and US metropolitan was com-
pared (31). Shared patterns of gut microbiome develop-
ment were identified during the first year of life in all
populations, and bifidobacteria was the most prevalent
group, dominating the infant microbiota of all three
groups during this period.
Host genetics
The relative contribution of the host genetics in shaping
the gut microbial structure and function is not yet clearly
defined and remains a subject of ongoing debate. Our
understanding of the importance of host genetics in this
regard is derived from studies in humans, animals, and
comparative species analysis (61).
In humans, the most valuable information is derived
from studies of twins and family relatedness. A DNA-
based finger-print analysis of the microbiota of human
adults with varying degree of relatedness ranging from
parents and children, non-twin siblings, monozygotic
twins, and unrelated subjects confirmed that host geno-
type has a significant effect on the composition of the
dominant bacteria, with monozygotic twins demonstrat-
ing the highest similarity in their microbiota (62). These
results were later substantiated by reanalysis using mole-
cular profiling methods (63). A study with children under
the age of 10 indicated that the degree of similarity in the
bacterial community was higher in identical compared
with non-identical twins and was lowest in the unrelated
control group (64). In contrast, a metagenomics study
using deep sequencing of samples from 31 monozygotic
and 23 dizygotic twin pairs and their parents did not
identify significant differences in bacterial diversity be-
tween the two types of twins, although the members of
the same family were found to share a higher numbers
of bacterial phylotypes (65, 66). It has been suggested
that if the impact of host genotype on microbiota is less
pronounced, detection of significant differences in healthy
populations may require analysis of larger cohorts (67).
Defining host genotypemicrobiota interactions in
humans is complicated due to the well-established influ-
ence of diet and other environmental and maternal factors
on the structure of the microbiota (see ‘Factors influen-
cing infant microbiota development’ section). The use
of genetically inbred lines of animals and germ-free and
specific knock-out mice can overcome such confounding
factors (68, 69). Eight different recombinant inbred lines,
reflecting the genetic diversity found in humans, were
profiled using ARISA-based fingerprinting methods (70).
This study showed that genetic background significantly
altered the composition of the microbiota but indepen-
dently of the mouse gender, a somewhat surprising finding
since differences in hormonal types and levels would
be expected to have an influence on the gut microbiota.
Using parental BALB/c and C57BL/6J mice and their
reciprocal cross F1 hybrid, Buhnik-Rosenblau et al. (71)
showed that host genetics had a major impact on the
composition and level of colonization of the mouse gut by
Lactobacillus johnsonii, a potential probiotic bacterium.
However, the molecular mechanisms by which specific
host genes are responsible for shaping the gut micro-
biota are so far mainly derived from single gene studies
although several genome-wide association studies are be-
ginning to provide detailed insights into host genotype
microbiota interactions (67, 72). In another study, an
Apoe-I knockout mouse with impaired glucose tolerance
was used to assess the interaction between host genetics,
diet, and the development of metabolic syndrome. Mole-
cular profiling with pyrosequencing of 16S rRNA genes
revealed that the Apoe-I genetic mutation contributed
The gut microbiota throughout life
Citation: Microbial Ecology in Health & Disease 2015, 26: 26050 - http://dx.doi.org/10.3402/mehd.v26.26050 5
(page number not for citation purpose)
to 12% of the total structural variation in the gut micro-
biota, whereas dietary changes contributed 57% of the
observed microbiota modulation (73). The effect of leptin
deficiency resulting in obese phenotype has been exten-
sively studied and shown to have a major impact on the
gut microbiota composition, with the obese mice showing
deceased levels of Bacteroides spp. (74). Understanding
specific host traits associated with microbial interac-
tions provides invaluable clues to identify the underlying
mechanisms of microbiota modulation. Modulation via
the immune system has already been suggested, but other
host-genome polymorphisms leading to an alteration
of the gut microbiota structure and function in a host-
dependent manner also need to be considered. These
include, among others, mucus production and mucin
glycan modification (see next section ‘Mucin glycosyla-
tion’), bile metabolism (75), host-derived antimicrobial
peptides (76), and mammalian hormones (77, 78).
There is now clear evidence that the host genotype
influences the structure of the gut microbiota and even
single gene mutations can lead to alterations of the
microbiota composition. Detailed genome-wide associa-
tion studies in humans are needed to provide a greater
understanding of the mechanisms underlying gut micro-
biota and host genotype interactions and guide future
microbiota-targeted intervention strategies.
Mucin glycosylation
The mucus layer overlies the intestinal epithelium and
forms the anatomical site at which the microbiota first
encounters the host. In addition to its association with
the protection, lubrication and hydration of the intesti-
nal epithelium, mucus plays a critical role in the main-
tenance of intestinal homeostasis by promoting microbial
interactions with commensal bacteria, acting as decoys
for pathogens and enhancing immune regulation (79).
The thickness, composition, organization, and glycosyla-
tion pattern of the mucus layer varies along the GI tract
and correlates with the association of distinct microbial
communities with the mucosal surface (80). The major
structural components of mucus are mucins, a family of
high-molecular-mass glycoproteins (81, 82). To date, 22
human mucins have been identified and can be classified
into two main categories, secreted and membrane-bound
mucins (83). In the intestine, MUC2 is the predominant
secretory mucin produced by goblet cells. Eight core
structures of the mucin O-glycan chain have been iden-
tified (84), with core-1-4 glycans most commonly found
in intestinal mucins (Fig. 2).
The mucus-binding capacity of microbes increases
their colonization ability at the mucosal interface and
prolongs intestinal residency of beneficial microbes (85).
Furthermore, bacterial adhesion to mucin glycans may be
a mechanism by which the host selects bacterial species
that present the complementary set of adhesins (86). The
link between glycosylation of the intestinal mucus layer
and microbiota composition has been highlighted in
studies using mouse models deficient in specific mucin
glycosyltransferase genes (8793). Furthermore, recent
work showed that host-derived fucose signaling, activated
through the microbiota, can modulate pathogenic intest-
inal colonization (94, 95) indicating that mucin glycosy-
lation has a selective capacity on microbial ecology. The
loss of the a-1,2-fucosyltransferase FUT2, and therefore
fucosylated host glycans, leads to a decreased diversity
and differences in community composition in mice (87),
whereas an association between the composition of the
intestinal microbiota and the ABO blood group or
Fig. 2. (a) Classification of human mucins into secreted (gel-forming and non-gel-forming) and membrane-bound mucins (MUCs).
(b) The four common mucin type O-glycans (core-1-4) found in the GI.
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FUT2 secretor status was reported in humans (96, 97).
Host glycan-mediated alteration in the microbiota is
also associated with increased susceptibility to infection
and inflammatory bowel diseases (IBD) (98100). These
findings may explain the region-specific colonization of
the GI tract and the likely influence of mucin glycosyla-
tion in selecting successive colonization of the intestine
by gut bacteria throughout life. Earlier work investigat-
ing mucin gene expression in human embryonic and fetal
intestine showed that mucin genes are expressed from the
early mid-trimester of gestation and aberrations in ex-
pression may play a role in the development of intestinal
disease (101103).
More recently, MUC2 was implicated in the etiology
of NEC, the most common GI cause of morbidity in
premature infants (104). Goblet cells are significantly
decreased in NEC, and the presence of functional MUC2
plays a critical role in the prevention of this disease (105).
It is also important to note that abnormal gut coloniza-
tion is a hallmark of NEC (106, 107), and that human
milk (whose oligosaccharide structures are similar to
mucin glycans) is associated with reduced NEC risk
compared to formulas (108, 109), supporting a particular
role for mucin-type O-glycans in microbial colonization.
Both human adult and fetal intestinal samples have
been shown to contain the sialic acid Neu5AC as their
most abundant component, with the level of expression
of Neu5,8Ac2 in fetuses being higher compared to the
adult intestine (110). In contrast to human adult intestinal
mucins, an increasing gradient of sialic acid or decreasing
gradient of fucose was not observed from ileum to distal
colon in the fetal intestine (110112). These findings
suggest that region-specific glycosylation of the human
intestine is acquired after birth, probably due to bacterial
colonization and gut postnatal absorptive and digestive
functions. Indeed, several studies have reported the in-
fluence of major commensal bacteria on the production of
mucus, mucin glycans, and the development of goblet
cells (113115). Microbial profiling during the process of
microbial colonization in germ free mice showed that the
abrupt increase in the ratio of fucosylated to sialylated
glycans during the initial stage of colonization correlates
with the establishment of Bacteroidetes members (116)
known to sense and regulate fucose (94, 95, 117).
Further studies in germ free animals suggested that the
simultaneous establishment of lactate-producing (e.g.
Bifidobacterium adolescentis) and sulfate-liberating (e.g.
Bacteroides spp.) bacteria during the initial stage of
microbial colonization, as well as the availability of
sulfated mucins, promoted a bloom in sulfate-reducing
bacteria (118, 119), as reviewed recently by El Aidy et al.
(120). Altogether these studies provide an insight into how
bacterial communities adapt to changing mucin glycan
profiles throughout life, and a possible mechanism of
niche-development. However, a substantial amount of
research is necessary to define the causal relationship
between mucus development and bacterial succession
at a mechanistic level. This link is of particular impor-
tance to increase our understanding of intestinal diseases
where alterations in mucus secretion, mucin glycosylation,
and microbial involvement are apparent, in particular in
IBD and pre-malignant and malignant lesions.
Impact on development of child health
The world is experiencing a progressive increase of
metabolic and immune mediated diseases, with a drama-
tically high increase in infant populations. This increase
may be related to a parallel increase in the rates of
C-section deliveries, which has exponentially increased
far beyond the 15% recommended by the World Health
Organization. Indeed, birth by C-section has been asso-
ciated with the development of allergy and asthma, as
well as type I diabetes, celiac disease and obesity
(121124). Allergic diseases comprise the most common
chronic disease in childhood while obesity is the most
prevalent nutritional problem in Western countries.
Allergic diseases
Allergic diseases have become a major public health
problem in affluent societies (125). As changes in the
genotype cannot explain such a rapid increase in the
allergy prevalence, loss of protective factors or/and new
risk environmental factors may contribute to the in-
creased prevalence of these diseases since the middle of
the last century (125). A reduced intensity and diversity
of microbial stimulation may have resulted in an abnor-
mal immune maturation in early childhood (126, 127).
The developing neonatal immune system may depend
on anticipated diverse inputs to mature normally, much
like the central nervous system does (128). As other
immune-mediated diseases such as multiple sclerosis, type
I diabetes, and Crohn’s diseases also show rising in-
cidences in economically developed countries (126, 128,
129), a theory of ‘microbial deprivation syndromes of
affluence’ has been proposed (126, 127). A limited
microbial pressure, resulting in insufficient T cell induc-
tion with regulatory and/or Th1-like properties to coun-
teract allergy-inducing Th2 responses, may underlie this
allergy epidemic (126, 130, 131).
The Th2-skewed state of the neonatal immune system
(126, 132) is likely a consequence of the fetal immune
environment during pregnancy (133). The fetalmaternal
interface is characterized by high levels of Th2-like
(134, 135) and anti-inflammatory (136) cytokines, as
well as enrichment of T regulatory cells (137), most likely
functioning to divert the maternal immune response
away from damaging Th1-mediated immunity (138, 139).
This neonatal Th2-skewing is even more marked in infants
later developing allergic disease (132, 140, 141), support-
ing the notion that the prenatal immune environment
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can influence allergy development (133, 142). The neona-
tal Th2-bias should then develop toward a more balanced
immune phenotype, including appropriate development
of regulatory T cell responses (126) and maturation of
Th1-like responses (131, 132). A failure of Th2-silencing
during immune system maturation may underlie develop-
ment of Th2-mediated allergic disease (126, 132, 143).
Appropriate pre- and postnatal microbial stimulation may
be needed to avoid this pathophysiological process
(144, 145). In this respect, the gut microbiota is quantita-
tively the most important source of microbial stimulation
and may provide a primary signal for the maturation
of a balanced postnatal innate and adaptive immune
system (126, 127, 146150).
Early gut microbiota differences between infants who
later do or do not develop allergic disease have been
reported (151160). There is considerable inconsistency
between the results from the different studies and large
differences in the microbiological techniques employed,
however (151161). It is also important to bear in mind
that assessments of stool samples reflect luminal colonic
microbiota and not necessarily the colonization of the
small intestine, where the major part of the gut immune
system is situated (162, 163). No specific microbes with
consistently harmful or allergy protective roles have
yet been identified; however, some studies have found
associations between low rates of bifidobacteria (151, 152,
156, 164) or lactobacilli (156, 164) colonization during
infancy and later allergy development. In addition, some
studies have found evidence for early Clostridium difficile
colonization as a risk factor for later allergy development
(151, 153, 165, 166). As C. difficile is an opportunistic
pathogen, expanding when gut microbiota niches are
vacant (44), the increased detection rate of this bacterium
in infants later developing allergy suggest that disrup-
tions in infant gut microbial ecology precede disease
development.
Early establishment of a diverse gut microbiota may
be more important than the distribution of specific
microbial species in shaping a normal immune matura-
tion, with repeated exposure to new bacterial antigens
enhancing the development of immune regulation (44,
126, 127, 167). In support of this theory, studies using
cultivation-independent molecular techniques such as de-
naturing gradient gel electrophoresis (155, 157) or term-
inal restriction fragment length polymorphism (154, 159)
of bacterial 16S rRNA phylotypes, demonstrated a low
gut microbiota diversity during infancy in children devel-
oping eczema (154, 155, 159) or sensitization (157).
The diversity within specific microbial phyla or genera
cannot be identified with these types of molecular
methods, however, and the sensitivity appears low as the
median number of peaks/bands was much lower than
the expected number of bacterial species (154, 155, 157,
159). Employing more sensitive and powerful next-
generation high-throughput barcoded 16S rRNA gene
454-pyrosequencing, we could demonstrate that develop-
ment of atopic eczema was preceded by a low diversity
of the total microbiota at 1 month and a low diversity
of the bacterial phylum Bacteroidetes and the genus
Bacteroides at 1 month (158). Interestingly, a Western
lifestyle with a low dietary fiber intake has been asso-
ciated with a gut microbiota depleted of Bacteroidetes (60).
Mice that fed a high-fiber diet had increased Bacteroidetes
abundance, leading to enhanced circulating short-chain
fatty acid levels and protection against allergic inflamma-
tion in the lung (168). Furthermore, delivery by C-section,
a risk factor for allergy development (124, 127), was asso-
ciated with decreased relative abundance and diversity
within the Bacteroidetes phylum during the first year
of life and less frequent detection of the major genus
Bacteroides (35). We also demonstrated that the presence
of the genus Bacteroides at 1 month was associated with
high levels of the Th1-associated chemokines CXCL10
and CXCL11 during infancy (35). Further supporting the
concept of the importance of early gut microbiota diver-
sity in driving normal immune maturation, we recently
found that children developing asthma at school age had a
lower diversity of the total microbiota than non-asthmatic
children at 1 week and 1 month of age (169). Speculatively,
as viral lower respiratory tract infections (LRTIs) are
particularly linked to asthma development among atopic
children (125), a reduced mucosal barrier function could
be a consequence of a less diverse microbial stimulation.
This may be linked to high susceptibility of LRTIs, am-
plification of Th2 responses, and subsequent asthma
development (125).
The continuously decreasing cost/throughput ratio of
current sequencing platforms will allow analysis of the
gut microbiota in larger pediatric cohorts with increased
sensitivity and depth to further establish how the infant
gut microbiota shapes immune and allergy development
(127). Novel next-generation probiotic candidates may
be identified in such studies, for example, indigenous
gut bacteria-producing Treg-promoting short-chain fatty
acids (170172) and immunomodulatory Bacteroides
strains (173). Probiotic interventions have so far failed
to prevent asthma (174177), although promising pre-
ventive effects have been observed for atopic eczema (127,
178180). The preventive effects on eczema have primarily
been observed in studies with combined pre- and post-
natal administration with probiotic lactobacilli, although
prenatal probiotic supplementation has not been given
until the last trimester of pregnancy (127, 145, 178181).
If prenatal microbial exposure is vital for the preventative
effect, the use of probiotics during the last trimesters of
pregnancy, when circulating fetal T cells have developed,
may have a relevant role in allergy and asthma prevention
(145, 181). Such studies using traditional probiotics
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are now ongoing and similar interventions with next-
generation probiotics may be tested in the future.
Obesity and related disorders
Obesity is among the major current health problems,
which are increasing rapidly worldwide. Obesity is asso-
ciated with a heightened risk of Western lifestyle diseases
such as type 2 diabetes, cardiovascular diseases, sleep,
and apnea, and also increases the mortality risk (182).
The role of the gut microbiota in the development
of these conditions (also known as metabolic syndrome)
is discussed in a separate review in this supplement
(dysbiosis of the gut microbiota in disease). However,
there is evidence that the development of metabolic
syndrome is affected by the gut microbiota early in life.
Excessive weight increments during the first month
of life have been associated with a high risk of obesity
development at 3 years of age (183). These results link with
observations of early microbial differences in infants
developing obesity at school age (184). This study reported
lower Bifidobacterium levels and a higher prevalence of
Staphylococcus during the first year of life in obese infants
compared to those with a normal weight at 7 years of age.
Excessive weight gain may begin during the fetal
period, as overweight mothers supply excessive energy to
the fetus and problems with weight often persist from
childhood to adulthood (185, 186). In obese pregnant
women, a vicious circle of non-favorable metabolic de-
velopment maybe generated if their altered gut micro-
biota composition is transferred to the infant (187189).
Furthermore, specific shifts in microbial composition
were also associated with maternal factors such as BMI,
weight, and weight gain over pregnancy (188189). Infants
from women with normal weight gain over pregnancy
show higher levels of bifidobacteria than women with
excessive weight gain, suggesting the potential role of
Bifidobacterium group on infant microbiota and weight
development (189). A relationship between the gut micro-
biome and maternal nutritional status during pregnancy
has been reported (189, 190). Interestingly, both studies
are supportive of the view that a gut microbiota profile
favoring a higher number of Bifidobacterium spp. and
a lower proportion of Staphylococcus spp. may provide
protection against maternal excess weight development.
Furthermore, a lower abundance of Bifidobacterium spp.
in the milk microbiota of mothers with atopic disease
compared with healthy mothers has been observed (191),
and a similar difference is seen between healthy and
obese mothers (188). The higher levels of bifidobacteria
found in healthy infants are also in accordance with the
protective role attributed to breast-feeding against devel-
oping obesity and other diseases later in life (192) and
the predominance of bifidobacteria in the gut of breast-
fed babies (193). The administration of probiotics during
pregnancy is under consideration because of the positive
effects that some strains exert on certain clinical condi-
tions. It has been reported that probiotic consumption
reduced the risk of central adiposity during the following
6 months after delivery (194). Other studies have provided
clinical evidence of improved plasma glucose concentra-
tions and insulin sensitivity during pregnancy and also
12 months after delivery when advantageous dietary intake
is combined with probiotics (195). Maternal administra-
tion of Lactobacillus rhamnosus GG before and after
delivery has been reported to induce specific changes
in the initial neonatal colonization of bifidobacteria and
also influences the breast milk microbiota compared
with those receiving placebo (196). Interestingly, nutrition
counseling and probiotic intervention were shown to
reduce the risk of fetal overgrowth associated with gesta-
tional diabetes (197). Perinatal probiotic intervention
was able to moderate the increased weight gain mainly in
infants who later became overweight during the first
years of life (198).
Therefore, microbiota modulation by probiotics early
in life is receiving great interest. There is a ‘window of
opportunity’ during the first months of life where the
microbial colonization and immune system maturation
are still in progress. Taken together, long-term health
benefits for mothers and children may be conferred by
balanced maternal nutrition during pregnancy influencing
the infant microbiota and immune system development
which impact on early and late health.
The composition and stability of the adult gut
microbiota
The specific microbial diversity present in healthy adult
subjects plays an important role in maintaining immune
homeostasis. This links with the fact that microbiota
alterations are related to gut-related diseases (199). Due
to the important role of the microbiota in health, studies
using next-generation sequencing methodologies are
aimed at identifying and characterizing microbial diver-
sity and functionality. While different projects have
attempted to identify and describe the microbial compo-
sition in healthy subjects, this has been really difficult
due to the high variation between individuals, the studied
samples, and also, the methodology applied for that
purpose. Furthermore, the composition that is typically
measured is that which can be isolated from fecal
samples, and this does not truly reflect the full diversity
of the GI tract. This disconnects between fecal sample
analysis, and the true composition of the different niches
in the GI tract will need to be bridged if we are to better
understand the role of the gut microbiota in human
biology. Until we have technologies to bridge this gap,
fecal samples and limited biopsy samples will still be used
as proxies for the large intestinal microbiota. So as
we enter the second decade of research into the gut
microbiota, we are still faced with the reality that the
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descriptions that we provide of the composition and the
functions may be misleading, but are currently our best
guesses.
The current census, which is collated from numerous
studies mainly based in developed countries, is that the
gut microbiota in the large intestine is a two-phylum
coalition comprising members of the Firmicutes and
Bacteroidetes (24, 65). The next most abundant phylum
is the Actinobacteria, which is mainly comprised of the
genus Bifidobacterium. This consensus has been derived
from thousands of fecal samples using inventories of the
16S rRNA gene, generated mainly on next-generation
sequencing platforms such as the Roche 454 and Illumina
systems. Hence, they represent snapshots in time of the
composition of a stool sample, which may or may not have
been residing in the rectum prior to sampling. Addition-
ally, this approach can only really robustly identify
bacteria down to the genus level and in some instances
the species level, and does not capture fully the com-
plete species or strain diversity within a sample or an
individual. However, the striking conclusion is that an
individual’s large intestinal gut microbiota sits on a con-
tinuum, which at one end is predominantly composed
of members from the phylum Bacteroidetes, and at the
other end is predominantly composed of Firmicutes.
Additionally, when an individual’s large intestinal gut
microbiota has reached its stable climax community, it
appears to be stable for a significant period of time as
Faith and colleagues showed (200). This study followed
37 health adults and reported that after 5 years 60%
of the original strains were still present. One can spe-
culate on the value of such stability as it benefits the host
to provide a niche which ensures that important functions
of the microbiome are always present. Moreover, this
stability may also be of benefit to the innate immune
system, as it will also be sensing the same microbiota
and thus not respond to it.
While there are many studies on the diversity of the
large intestine, few studies have attempted to investigate
the diversity of the small intestine. These studies show
that the small intestine contains mainly members of the
streptococci and variable numbers of bacteria belong-
ing to the genera Clostridium and Veillonella (201, 202).
Additionally, unlike the large intestine, the bacterial
composition shows temporal fluctuations, with the morn-
ing and afternoon profiles being significantly different.
This dynamic nature will be driven in part by the frequent
input of dietary components and will vary between
individuals depending on the diet (203).
The gut microbiota in the elderly
The gut microbiota in the aging population has been the
focus of much attention in recent years. Several studies
(e.g. ELDERMET in Ireland and CENIT in Spain) are
aimed at characterizing the microbiota of individuals
as they progress into old age so that changes in micro-
bial populations that are associated with aging can be
determined. Such changes may be related to a decline
in general health and well-being in the elderly and as
such, the results of these studies may shed light on how
we can manipulate the gut microbiota (using better
nutrition and/or probiotics) to promote improved health.
The microbiota of elderly people (65 years old) has
been reported to show greater inter-individual variation
than adults (204). This study also reported a link between
gut microbiota composition, diet, and living in institution
or community. Furthermore, centenarians had a different
and less diverse microbiota than adults and younger
elderly people (205). A large group of volunteers over
100 years old had increased facultative anaerobes, such
as Proteobacteria and Bacilli, and a decrease in specific
bacteria, such as Faecalibacterium prauznitzii and Clos-
tridium cluster XIVa bacteria. It was also reported
that centenarian’s microbiota show a decreased levels
of Bacteroides, Bifidobacterium and Enterobacteriaceae,
while Clostridium spp. levels were increased compared with
younger adults (206). The relevance of these observed
changes during aging are not yet fully understood and
future studies (particularly dietary-intervention studies)
are required to investigate whether changing the dietary
pattern of elderly individuals can alter their gut microbiota
in a way that is beneficial to their general health.
Strategies for microbiota modulation
During infancy the intestinal microbiota is less stable
and more variable in its composition than in older children
and adults. As diet plays a major role in the development
of microbiota during this period, there is an opportunity
for its manipulation. Generally the microbiota composi-
tion of the large intestine is considered to be quite stable
(200, 207), although long-term metabolic effects can be
observed even after transient perturbations of the micro-
biota in early life (208), while the composition of the
small intestine is very dynamic and this reflects the daily
input of dietary components into the system. In both
cases, it is relatively easy to perturb the composition of
the gut microbiota, for example, by diet, antibiotics, and
GI surgery. Since it is difficult to investigate the small
intestine, we are still unsure as to what impact dietary
supplements, such as probiotics, have on the composition
in this area of the intestinal tract. In the area of antibiotics,
there is well-documented evidence that non-specific anti-
biotics, when taken orally, will cause collateral damage
and kill off many of the organisms within the large
intestine (209), but the gut microbiota shows remarkable
resilience and can re-attain its original composition within
a short period of time once the antibiotic intervention
has been removed. However, subtle and long-term changes
in the gut microbiota have been observed in response
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to antibiotic treatment (210, 211), although the effect on
health of such changes is so far unclear.
Two of the most common approaches are interventional
and involve an individual taking live organisms, probio-
tics, or a non-digestible carbohydrate, a prebiotic. The
probiotic approach has been shown to be efficacious
only in a few diseased cases, for example, in reducing the
rates of NEC in preterm infants (212) and diarrhea (213).
There is little evidence that they make any impact on the
large intestinal composition, however. But one must not
lose sight of the fact that these organisms may be having
a significant impact in the small intestine, where they
will be a significant proportion of the total community.
The other dietary intervention, known as prebiotics, can
have a major impact on the large intestine, when taken
in significant quantities. However, many of these studies
are in animal models and fail to translate through to real-
world instances, for example, the equivalent dose of the
prebiotic in humans equates to 50 g a day, which can
result in many unpleasant side effects. Modification of the
diet without a direct intervention, for example, changing
the proportions of protein, carbohydrates, and fat, also
changes the composition of the gut microbiota in the
large intestine (200, 214). As we understand more about
the establishment of the gut microbiota in healthy infants,
it may be possible to determine which core bacterial
species are required for the establishment of a ‘healthy’
microbiota. In future, we may be able to identify infants
at risk of developing microbial dysbiosis (e.g. infants
delivered by C-section, or infants with a history of
antibiotic treatment) and manipulate their microbiotas
during a window of opportunity (e.g. with cocktails of
probiotics) to help establish a stable, healthy microbiota
throughout life.
Conclusions
In the past 10 years, our understanding of the com-
position of the adult gut microbiota has undergone a
significant change. We have moved from a position in
which the predominant organisms in the gut microbiota
were thought to be those that were grown easily on
laboratory media, to one in which we now know that
the gut microbiota is complex and host-specific (214).
Furthermore, we now understand that while the majority
of the most abundant bacteria can be grown in the
laboratory, the bulk of the organisms cannot (214).
Thus, if we are to understand the contribution of these
organisms to host biology and move medicine into the 21st
century, we need to be able to not only understand ‘who
is there’, but also be able to determine ‘what they are
doing’ and how these functions interact with the host.
Therefore, the ecological and functional properties of a
healthy gut microbiome in infants, children and adults
still need to be identified.
While the infant gut microbiota seems to influence
immune development and metabolic pathways, further
studies on the appropriate timing of interventions and the
complex interactions between the infant immune system
and the gut microbiota are required to translate these
findings into preventive strategies required to reduce the
risk of disease. Strategies to treat conditions associated
with a disrupted gut microbial ecology and inflamma-
tion in adults also represent important areas of future
research. While the area of gut microbiology is not new
and has received serious interest for over 100 years,
technological advancements in the last decade have really
allowed us to interrogate it in a manner which was
unforeseen 20 years ago.
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